On the other hand, revenue from dental and medical clinics remained flat y-o-y at $39.2 million during the third quarter.
On a 9MFY2022 basis, earnings were 51% lower y-o-y at $13.5 million, while revenue was 12% lower y-o-y at $133.4 million.
As at end Sept, the group has 106 dental outlets, five medical outlets and one dental college in operations in Singapore. Elsewhere, it has 45 dental outlets in Malaysia and one dental outlet in China.
During the period, cash and cash equivalents stood at $36.5 million.
See also: Creative guides for ‘similar level of operating loss’ for 2HFY2025
The group did not declare any dividends this period, as compared to 1.0 cents declared last year. The group said this was because it is conserving cash for corporate activities and future expansion which should be internally funded in the light of rising interest rate. In 4QFY2022, the group says that it will continue to pay down the bank loans.
Dr Ng Chin Siau, CEO of Q&M says: “Our core healthcare business remains resilient with good prospects for growth. Revenue has come in above $40 million for the eight consecutive quarters and it will continue to be the key contributor to the group’s revenue and profitability going forward.”
Meanwhile, with the group’s strategic investments in Artificial Intelligence (AI) for its dental business, Dr Ng adds: “The future of dentistry lies in combining the dentist's domain expertise and valuable experience with AI's data-centric analysis and ability to generate holistic dental healthcare plans that are specifically tailored to individual needs. This results in better patient management outcome and care which are the main objectives of all medical practice”
See also: Fortress Minerals earnings for 1QFY2026 up 7.2% y-o-y to US$2.48 mil
With that, Dr Ng is “cautiously optimistic” on the outlook if its core healthcare business.
Shares in Q&M last traded 1.45% higher on Nov 11 at 35 cents.
Photo: The Edge Singapore/ Albert Chua
